891 related articles for article (PubMed ID: 32855289)
1. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
Uncini A; Vallat JM; Jacobs BC
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
[TBL] [Abstract][Full Text] [Related]
2. A Case of Guillain-Barré Syndrome Associated With COVID-19.
Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
[TBL] [Abstract][Full Text] [Related]
3. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
[TBL] [Abstract][Full Text] [Related]
4. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
Agha Abbaslou M; Karbasi M; Mozhdehipanah H
Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review.
Diez-Porras L; Vergés E; Gil F; Vidal MJ; Massons J; Arboix A
Neuromuscul Disord; 2020 Oct; 30(10):859-861. PubMed ID: 32912716
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.
Sancho-Saldaña A; Lambea-Gil Á; Liesa JLC; Caballo MRB; Garay MH; Celada DR; Serrano-Ponz M
Clin Med (Lond); 2020 Jul; 20(4):e93-e94. PubMed ID: 32518103
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome after COVID-19 in Japan.
Hirayama T; Hongo Y; Kaida K; Kano O
BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33122241
[TBL] [Abstract][Full Text] [Related]
10. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital.
Ottaviani D; Boso F; Tranquillini E; Gapeni I; Pedrotti G; Cozzio S; Guarrera GM; Giometto B
Neurol Sci; 2020 Jun; 41(6):1351-1354. PubMed ID: 32399950
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome after covid-19 infection.
García-Manzanedo S; López de la Oliva Calvo L; Ruiz Álvarez L
Med Clin (Barc); 2020 Oct; 155(8):366. PubMed ID: 32718718
[No Abstract] [Full Text] [Related]
12. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
Juliao Caamaño DS; Alonso Beato R
J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
[TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection.
Chan JL; Ebadi H; Sarna JR
Can J Neurol Sci; 2020 Nov; 47(6):852-854. PubMed ID: 32468972
[No Abstract] [Full Text] [Related]
14. Guillain Barre syndrome associated with COVID-19 infection: A case report.
Sedaghat Z; Karimi N
J Clin Neurosci; 2020 Jun; 76():233-235. PubMed ID: 32312628
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome related to COVID-19 infection.
Alberti P; Beretta S; Piatti M; Karantzoulis A; Piatti ML; Santoro P; Viganò M; Giovannelli G; Pirro F; Montisano DA; Appollonio I; Ferrarese C
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32350026
[No Abstract] [Full Text] [Related]
16. Fatal Guillain-Barre syndrome after infection with SARS-CoV-2.
Marta-Enguita J; Rubio-Baines I; Gastón-Zubimendi I
Neurologia (Engl Ed); 2020 May; 35(4):265-267. PubMed ID: 32364124
[No Abstract] [Full Text] [Related]
17. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.
Hasan I; Saif-Ur-Rahman KM; Hayat S; Papri N; Jahan I; Azam R; Ara G; Islam Z
J Peripher Nerv Syst; 2020 Dec; 25(4):335-343. PubMed ID: 33112450
[TBL] [Abstract][Full Text] [Related]
18. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].
Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M
Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2-Associated Guillain-Barre Syndrome With Good Response to Plasmapheresis.
Granger A; Omari M; Jakubowska-Sadowska K; Boffa M; Zakin E
J Clin Neuromuscul Dis; 2020 Sep; 22(1):58-59. PubMed ID: 32833726
[No Abstract] [Full Text] [Related]
20. Guillain-Barré Syndrome Associated with SARS-CoV-2.
Toscano G; Palmerini F; Ravaglia S; Ruiz L; Invernizzi P; Cuzzoni MG; Franciotta D; Baldanti F; Daturi R; Postorino P; Cavallini A; Micieli G
N Engl J Med; 2020 Jun; 382(26):2574-2576. PubMed ID: 32302082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
